Locations:
Loading Complete
Reza Alaghehbandan

Reza Alaghehbandan, MD

Genitourinary Pathology

Highlights

Age Groups Seen

  • Adult

Languages

  • English

Gender

Male

About Reza Alaghehbandan

Biography

Reza Alaghehbandan, MD, is Professor of Pathology at the Cleveland Clinic Lerner College of Medicine (CCLCM) of Case Western Reserve University (CWRU) School of Medicine. He is an academic Surgical Pathologist with expertise in urologic pathology as well as a Clinical Epidemiologist. He is board-certified in Anatomic Pathology in the USA, Canada, and Europe, and is a Fellow of the College of American Pathologists (FCAP), the Royal College of Physicians and Surgeons of Canada (FRCPC), the International Academy of Cytology (FIAC), the American College of Epidemiology (FACE), the New York Academy of Medicine (NYAM). Prior to joining the Cleveland Clinic, he served as Clinical Professor of Pathology at the University of British Columbia (UBC) and the Department Head of Pathology at Royal Columbian Hospital in Vancouver, BC, Canada. Dr. Alaghehbandan’s primary research focus is on diagnostic and prognostic challenges in urologic pathology, with emphasis on developing risk stratification systems aiding clinical decision making for patient management and outcomes in renal and bladder tumors. He is a frequent speaker at national and international conferences and has authored numerous peer-reviewed articles. He is also a recipient of multiple teaching and philanthropic awards in both Canada and the USA.

Further to his scholarly activities, Dr. Alaghehbandan has served in various leadership and administrative roles and held positions in national and international committees. As a physician philanthropist, he has served as an International Academy of Pathology (IAP) Ambassador, with passion for global health and building capacity and highlighting the improvements pathologists can make for populations in resource-poor settings.

He continues to provide education and expertise in clinical services and translational research in low- and middle-income countries. His goal is to make a lasting impact in the world of global health and cancer control.

Locations

  1. Cleveland Clinic Main Campus
    • phone:
    • fax:

Education & Board Certifications

Education

  • Fellowship: Barnes-Jewish Hospital/Washington University School of Medicine, 2014
  • Residency: Memorial University of Newfoundland Faculty of Medicine, 2013
  • Residency: University of British Columbia Faculty of Medicine (Canada), 2012
  • Medical Education: Iran University of Medical Sciences, 2000
  • Internship: Iran University of Medical Sciences, 1998

Board Certifications

  • Anatomic Pathology: American Board of Pathology, 2013

Awards

  • John Beach Hazard Teaching Award 2023, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA 
  • Dr. Roberta Miller Resident Teaching Award 2022, Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of British Columbia (UBC), Vancouver, BC, Canada 
  • Community Engagement and Philanthropy Award, Pathology Day 2022, Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of British Columbia (UBC), Vancouver, BC, Canada 

Research & Publications

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2025-10-02, Dr. Alaghehbandan has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Insurances Accepted

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.